Astrazeneca (AZN) Net Margin (2009 - 2026)
Astrazeneca (AZN) recorded Net Margin of 20.69% in Q3 2026, up 3.06 percentage points from 17.63% a year earlier and up 4.39 percentage points from the prior quarter.
Powered by 
Analysis
Astrazeneca (AZN) Net Margin (2009 - 2026) Analysis & Trends
On a TTM basis, Astrazeneca's Net Margin came in at 18.58% as of Sep 30, 2026, up 1.51 percentage points year-over-year; for FY2025, it came in at 17.41%, up 4.40 percentage points from FY2024.
- Annual Net Margin has increased for four straight years, with a five-year change of +5.40 percentage points (FY2020 to FY2025).
- Across earlier years, Net Margin came in at 13.01% in FY2024 (+0.01 pp), 13.00% in FY2023 (+5.59 pp), 7.41% in FY2022 (+7.11 pp) and 0.30% in FY2021 (-11.71 pp).
- Quarterly Net Margin has ranged from -3.02% in Q4 2021 to 22.65% in Q1 2025 over the past five years.
- On a year-over-year basis, Net Margin rose in six of the last eight quarters, with an average year-over-year change of +2.76 percentage points.
- Peak year-over-year performance for Net Margin in the last five years was a gain of 31.89 percentage points in Q3 2022, against a drop of 18.14 percentage points in Q1 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at 16.30% (Q2 2026), 21.41% (Q1 2026) and 16.00% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn | 26.44% |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn | 0.83% |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn | 24.24% |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn | 28.01% |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn | 20.69% |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn | 37.28% |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn | 29.27% |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn | 19.55% |
| 10 | Vertex Pharmaceuticals | 136.55 Bn | 104.28 Bn | 2.91 Bn | 19.00% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 20.69% |
| Jun 30, 2026 | 16.30% |
| Mar 31, 2026 | 21.41% |
| Dec 31, 2025 | 16.00% |
| Sep 30, 2025 | 17.63% |
| Jun 30, 2025 | 16.93% |
| Mar 31, 2025 | 22.65% |
| Dec 31, 2024 | 11.23% |
| Sep 30, 2024 | 11.04% |
| Jun 30, 2024 | 14.90% |
| Mar 31, 2024 | 17.89% |
| Dec 31, 2023 | 8.48% |
| Sep 30, 2023 | 12.47% |
| Jun 30, 2023 | 15.94% |
| Mar 31, 2023 | 17.06% |
| Dec 31, 2022 | 8.04% |
| Sep 30, 2022 | 14.93% |
| Jun 30, 2022 | 3.34% |
| Mar 31, 2022 | 3.39% |
| Dec 31, 2021 | -3.02% |
API Access
Astrazeneca Net Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-margin&ticker=AZN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-margin", "ticker": "AZN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-margin&ticker=AZN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();